High-dose chemotherapy and blood stem cell autografts for children with first relapsed acute lymphoblastic leukemia: A pilot study of the children's cancer and leukemia study group of Japan (CCLSG)
- 1 January 1994
- journal article
- clinical trial
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 23 (1) , 20-25
- https://doi.org/10.1002/mpo.2950230105
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative StudyBlood, 1991
- Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM groupBlood, 1991
- Effectiveness of high-dose MCNU therapy and hematopoietic stem cell autografts treatment of childhood acute leukemia/lymphoma with high-risk featuresCancer, 1991
- MARROW TRANSPLANTATION FROM HLA-MATCHED UNRELATED DONORS FOR TREATMENT OF HEMATOLOGIC MALIGNANCIESTransplantation, 1991
- Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patientsBlood, 1991
- Early infectious complications after peripheral blood stem cell autografts in childrenMedical and Pediatric Oncology, 1991
- Bone marrow relapse occurring as first relapse in children with acute lymphoblastic leukemiaMedical and Pediatric Oncology, 1989
- Regimen-related toxicity in patients undergoing bone marrow transplantation.Journal of Clinical Oncology, 1988
- Comparison of Autologous and Allogeneic Bone Marrow Transplantation for Treatment of High-Risk Refractory Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1987
- Marrow transplantation for children with acute lymphoblastic leukemia in second remissionBlood, 1987